Oxford University study claims its AstraZeneca Covid vaccine’s effectiveness declines slower than Pfizer competitor ...News

Russia Today - News
Oxford University study claims its AstraZeneca Covid vaccine’s effectiveness declines slower than Pfizer competitor
The Pfizer-BioNTech vaccine’s protection against Covid “declines faster” than its Oxford-AstraZeneca competitor, with both less effective against the Delta variant, according to an Oxford University study released on Thursday. Announcing their findings, researchers from the UK-based university stated that, while the Pfizer vaccine had “greater initial effectiveness” against new infections, it “declines faster compared with two doses of Oxford-AstraZeneca.” While scientists expressed the need to conduct further investigation into the long-term effects of the vaccines, they suggested that initial findings show “that after four to five mo

Hence then, the article about oxford university study claims its astrazeneca covid vaccine s effectiveness declines slower than pfizer competitor was published today ( ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Oxford University study claims its AstraZeneca Covid vaccine’s effectiveness declines slower than Pfizer competitor )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News